This follows marketing authorization by Servicio Agricola y Ganadero (SAG), Chile’s Agricultural and Livestock Service, of Centrovet’s unique bi-valent ISA+SRS oral vaccine, which complements its already approved line of injectable and oral vaccines for use against major diseases that affect salmon and trout, including Atlantic salmon. The vaccine is delivered via commercial feed using ABN’s patented delivery systems.
David Farcas, Centrovet CEO, said: “This new vaccine is the beginning of our polyvalent oral vaccine strategy. This will undoubtedly be a major contribution to the aquaculture industry, allowing the fish to be vaccinated without the stress of injection and providing protection in half the time of injectable vaccines. It shows that boosting is an effective strategy to have fish protected until they are harvested.”
Farcas noted that the SRS and ISA fractions in the vaccine are the highest in the industry versus other preparations in the market place. The ISA fraction comes from specific antigens by recombinant yeast fermentation. He noted that this sophisticated method is used in vaccines against viral diseases throughout Europe and the US.
Source: ABN
© FoodBev Media Ltd 2024